{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:13Z","timestamp":1787242273403,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.rbmo.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T18:27:52Z","timestamp":1659896872000},"page":"352-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ovulation induction using sequential letrozole\/gonadotrophin in infertile women with PCOS: a randomized controlled trial"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-6915","authenticated-orcid":false,"given":"Xin","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiwen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7997-4358","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2022.08.002_bib0001","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2217\/WHE.15.19","article-title":"Infertility and miscarriage: common pathways in manifestation and management","volume":"11","author":"Agenor","year":"2015","journal-title":"Women's Health (Lond.)"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0002","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/humrep\/dex227","article-title":"Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome","volume":"32","author":"Amer","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0003","first-page":"33","article-title":"Pregnancies following the use of sequential treatment of metformin and incremental doses of letrozole in clomiphen-resistant women with polycystic ovary syndrome","volume":"10","author":"Azargoon","year":"2012","journal-title":"Iranian Journal of Reproductive Medicine"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0004","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/01443615.2010.497873","article-title":"Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial","volume":"30","author":"Badawy","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0005","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/humrep\/17.9.2219","article-title":"What is polycystic ovary syndrome? Are national views important?","volume":"17","author":"Balen","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0006","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00404-011-2091-7","article-title":"Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome","volume":"285","author":"Banerjee Ray","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2014.10.022","article-title":"Systematic review of cell adhesion molecules and estrogen receptor expression in the endometrium of patients with polycystic ovary syndrome","volume":"129","author":"Baracat","year":"2015","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0028-1087105","article-title":"Miscarriage and its associations","volume":"26","author":"Brown","year":"2008","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2007.05.025","article-title":"Aromatase inhibitors in ovarian stimulation","volume":"106","author":"Casper","year":"2007","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.12669\/pjms.326.11391","article-title":"Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome","volume":"32","author":"Chen","year":"2016","journal-title":"Pakistan Journal of Medical Sciences"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0011","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0012","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0013","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0014","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.fertnstert.2014.10.016","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review","volume":"103","author":"Franik","year":"2015","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/09513590.2022.2061454","article-title":"Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls","volume":"38","author":"Giordano","year":"2022","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1056\/NEJM200007063430101","article-title":"Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins","volume":"343","author":"Gleicher","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0017","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/humrep\/dei175","article-title":"Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: effects on pregnancy and multiple pregnancy rates","volume":"20","author":"Goverde","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0018","first-page":"1243","article-title":"Management of spontaneous abortion","volume":"72","author":"Griebel","year":"2005","journal-title":"American Family Physician"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0019","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fertnstert.2017.08.017","article-title":"In vitro fertilization treatments with the use of clomiphene citrate or letrozole","volume":"108","author":"Haas","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14647273.2016.1242783","article-title":"Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial","volume":"20","author":"Hassan","year":"2017","journal-title":"Human Fertility (Cambridge, England)"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rbmo.2011.03.024","article-title":"Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome","volume":"23","author":"He","year":"2011","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0022","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00404-018-4688-6","article-title":"Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"297","author":"Hu","year":"2018","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0023","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00404-012-2478-0","article-title":"Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial","volume":"286","author":"Ibrahim","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/09513590.2014.951321","article-title":"Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome","volume":"31","author":"Ito-Yamaguchi","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0974-1208.117166","article-title":"Current evidence supporting \u2018letrozole\u2019 for ovulation induction","volume":"6","author":"Kar","year":"2013","journal-title":"Journal of Human Reproductive Sciences"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0026","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0027","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/biolre\/ioy187","article-title":"Effects of letrozole and clomiphene citrate on Wnt signaling pathway in endometrium of polycystic ovarian syndrome and healthy women","volume":"100","author":"Mehdinejadiani","year":"2019","journal-title":"Biology of Reproduction"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0029","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.fertnstert.2007.08.060","article-title":"Effect of letrozole at 2.5 mg or 5.0 mg\/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination","volume":"90","author":"Noriega-Portella","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12958-021-00765-6","article-title":"Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome","volume":"19","author":"Ohara","year":"2021","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0032","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.beem.2018.10.002","article-title":"Pharmacology of medications used for ovarian stimulation","volume":"33","author":"Quaas","year":"2019","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0033","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00404-011-1951-5","article-title":"A randomized trial of ovulation induction with two different doses of letrozole in women with PCOS","volume":"284","author":"Ramezanzadeh","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.08.002_bib0035","first-page":"943","article-title":"Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness","volume":"50","author":"Ryan","year":"2005","journal-title":"The Journal of Reproductive Medicine"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0036","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.12669\/pjms.36.7.3345","article-title":"Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome","volume":"36","author":"Sakar","year":"2020","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"12","key":"10.1016\/j.rbmo.2022.08.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD013505","article-title":"Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome","volume":"12","author":"Sharpe","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0038","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0039","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0040","first-page":"j138","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0041","article-title":"Gonadotrophins for ovulation induction in women with polycystic ovary syndrome","volume":"1","author":"Weiss","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.05.022","article-title":"Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome","volume":"106","author":"Wu","year":"2016","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1016\/j.rbmo.2022.08.002_bib0043","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11995","article-title":"Association of metformin with pregnancy outcomes in women with polycystic ovarian syndrome undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0044","first-page":"6001","article-title":"Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study. Drug Design","volume":"9","author":"Xi","year":"2015","journal-title":"Development and Therapy"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0045","first-page":"31","article-title":"Role of insulin resistance index in the diagnosis of metabolic syndrome in people with different glucose tolerance","volume":"03","author":"Xing","year":"2004","journal-title":"Chinese Journal of Diabetes"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0046","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0047","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3349\/ymj.2015.56.2.490","article-title":"Minimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine insemination","volume":"56","author":"Yun","year":"2015","journal-title":"Yonsei Medical Journal"},{"key":"10.1016\/j.rbmo.2022.08.002_bib0048","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/09513590.2017.1292241","article-title":"Letrozole combined with low dose highly purified HMG for ovulation induction in clomiphene citrate-resistant infertile Chinese women with polycystic ovary syndrome: a prospective study","volume":"33","author":"Zhao","year":"2017","journal-title":"Gynecological Endocrinology"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648322005375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648322005375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:53:10Z","timestamp":1716922390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648322005375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1472648322005375"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2022.08.002","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovulation induction using sequential letrozole\/gonadotrophin in infertile women with PCOS: a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}